These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25629266)

  • 1. Protein and mRNA levels of YKL-40 in high-grade glioma.
    Kazakova MH; Staneva DN; Koev IG; Staikov DG; Mateva N; Timonov PT; Miloshev GA; Sarafian VS
    Folia Biol (Praha); 2014; 60(6):261-7. PubMed ID: 25629266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.
    Horbinski C; Wang G; Wiley CA
    Int J Clin Exp Pathol; 2010 Jan; 3(3):226-37. PubMed ID: 20224722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.
    Antonelli M; Buttarelli FR; Arcella A; Nobusawa S; Donofrio V; Oghaki H; Giangaspero F
    J Neurooncol; 2010 Sep; 99(2):209-15. PubMed ID: 20174854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.
    Iwamoto FM; Hottinger AF; Karimi S; Riedel E; Dantis J; Jahdi M; Panageas KS; Lassman AB; Abrey LE; Fleisher M; DeAngelis LM; Holland EC; Hormigo A
    Neuro Oncol; 2011 Nov; 13(11):1244-51. PubMed ID: 21831900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol represses YKL-40 expression in human glioma U87 cells.
    Zhang W; Murao K; Zhang X; Matsumoto K; Diah S; Okada M; Miyake K; Kawai N; Fei Z; Tamiya T
    BMC Cancer; 2010 Oct; 10():593. PubMed ID: 21029458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between YKL-40 and adult primary astrocytoma.
    Zhang W; Kawanishi M; Miyake K; Kagawa M; Kawai N; Murao K; Nishiyama A; Fei Z; Zhang X; Tamiya T
    Cancer; 2010 Jun; 116(11):2688-97. PubMed ID: 20499402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A complex of nuclear factor I-X3 and STAT3 regulates astrocyte and glioma migration through the secreted glycoprotein YKL-40.
    Singh SK; Bhardwaj R; Wilczynska KM; Dumur CI; Kordula T
    J Biol Chem; 2011 Nov; 286(46):39893-903. PubMed ID: 21953450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of pERK and pAKT in pediatric high grade astrocytomas: correlation with YKL40 and prognostic significance.
    Antonelli M; Massimino M; Morra I; Garrè ML; Gardiman MP; Buttarelli FR; Arcella A; Giangaspero F
    Neuropathology; 2012 Apr; 32(2):133-8. PubMed ID: 21978279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CDC25B expression in gliomas.
    Nakabayashi H; Hara M; Shimizu K
    J Clin Pathol; 2006 Jul; 59(7):725-8. PubMed ID: 16803948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.
    Tanwar MK; Gilbert MR; Holland EC
    Cancer Res; 2002 Aug; 62(15):4364-8. PubMed ID: 12154041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. YKL-40 expression in human hepatocellular carcinoma: a potential biomarker?
    Xiao XQ; Hassanein T; Li QF; Liu W; Zheng YH; Chen J
    Hepatobiliary Pancreat Dis Int; 2011 Dec; 10(6):605-10. PubMed ID: 22146624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
    Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
    Yu S; Pu P; Jiang D; An T; Guan X; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma.
    Pelloski CE; Mahajan A; Maor M; Chang EL; Woo S; Gilbert M; Colman H; Yang H; Ledoux A; Blair H; Passe S; Jenkins RB; Aldape KD
    Clin Cancer Res; 2005 May; 11(9):3326-34. PubMed ID: 15867231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental anti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma.
    Saidi A; Javerzat S; Bellahcène A; De Vos J; Bello L; Castronovo V; Deprez M; Loiseau H; Bikfalvi A; Hagedorn M
    Int J Cancer; 2008 May; 122(10):2187-98. PubMed ID: 18092325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.
    Nutt CL; Betensky RA; Brower MA; Batchelor TT; Louis DN; Stemmer-Rachamimov AO
    Clin Cancer Res; 2005 Mar; 11(6):2258-64. PubMed ID: 15788675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.
    Boado RJ; Black KL; Pardridge WM
    Brain Res Mol Brain Res; 1994 Nov; 27(1):51-7. PubMed ID: 7877454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biology and treatment of malignant glioma.
    Prados MD; Levin V
    Semin Oncol; 2000 Jun; 27(3 Suppl 6):1-10. PubMed ID: 10866344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.